111 related articles for article (PubMed ID: 28062022)
1. Diabetic Pharmacotherapy and Endometrial Cancer Risk Within a Publicly Funded Health Care System.
Kwon JS; Albert AY; Gill S; Hutcheon JA
J Obstet Gynaecol Can; 2017 Jan; 39(1):42-48. PubMed ID: 28062022
[TBL] [Abstract][Full Text] [Related]
2. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
4. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
Tian J; Liang Y; Qu P
Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
[TBL] [Abstract][Full Text] [Related]
6. Metformin and the risk of endometrial cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Gynecol Oncol; 2013 Jun; 129(3):565-9. PubMed ID: 23523618
[TBL] [Abstract][Full Text] [Related]
7. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
9. Metformin is associated with improved survival in endometrial cancer.
Ko EM; Walter P; Jackson A; Clark L; Franasiak J; Bolac C; Havrilesky LJ; Secord AA; Moore DT; Gehrig PA; Bae-Jump V
Gynecol Oncol; 2014 Feb; 132(2):438-42. PubMed ID: 24269517
[TBL] [Abstract][Full Text] [Related]
10. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
11. Metformin use and endometrial cancer survival.
Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Frimer M; Conroy E; Goldberg GL; Einstein MH
Gynecol Oncol; 2014 Jan; 132(1):236-40. PubMed ID: 24189334
[TBL] [Abstract][Full Text] [Related]
12. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes.
Hagberg KW; McGlynn KA; Sahasrabuddhe VV; Jick S
Br J Cancer; 2014 Oct; 111(9):1710-7. PubMed ID: 25093492
[TBL] [Abstract][Full Text] [Related]
13. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
14. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
[TBL] [Abstract][Full Text] [Related]
16. Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence.
Hall C; Stone RL; Gehlot A; Zorn KK; Burnett AF
Int J Gynecol Cancer; 2016 Feb; 26(2):313-7. PubMed ID: 26588235
[TBL] [Abstract][Full Text] [Related]
17. [Diabetes mellitus and endometrial cancer].
Kaneuchi M
Nihon Rinsho; 2016 Apr; 74 Suppl 2():437-41. PubMed ID: 27266131
[No Abstract] [Full Text] [Related]
18. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
[TBL] [Abstract][Full Text] [Related]
19. Association between metformin use and risk of prostate cancer and its grade.
Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
[TBL] [Abstract][Full Text] [Related]
20. Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
Lemon LS; Orr B; Modugno F; Buckanovich RJ; Coffman L; Edwards RP; Taylor S
Gynecol Oncol; 2022 Apr; 165(1):60-66. PubMed ID: 35140015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]